QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

IRON

QT80Disc Medicine, Inc.
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
70.79
+0.58+0.83%
OverviewShort InterestFilings
IRONQT80Disc Medicine, Inc.·NASDAQ
OverviewShort InterestFilings
70.79+0.83%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-
Insider Own23.89%
Shs Outstand38.20M
Perf Week3.98%
Market Cap2.68BForward P/E-EPS next Y-7.37Insider Trans-0.06%Shs Float-Perf Month10.49%
Enterprise Value2.62BPEG0.24EPS next Q-1.71Inst Own-Short Float-Perf Quarter19.64%
Income-239767049.00P/S0.00EPS this Y-Inst Trans-Short Ratio-Perf Half Y-22.61%
Sales-P/B3.93EPS next Y-5.98%ROA-32.20%Short Interest-Perf YTD-10.86%
Book/sh18.01P/C-EPS next 5Y-ROE-36.95%52W High99.49 -28.85%Perf Year41.44%
Cash/sh19.11P/FCF-EPS past 3/5Y-ROIC-36.91%52W Low40.00 76.98%Perf 3Y-
Dividend Est.-EV/EBITDA-11.01Sales past 3/5Y-Gross Margin0.00%Volatility2.93% 3.07%Perf 5Y-
Dividend TTM-EV/Sales0.00EPS Y/Y TTM-67.17%Oper. Margin0.00%ATR (14)3.09Perf 10Y-
Dividend Ex-Date-Quick Ratio24.00Sales Y/Y TTM-Profit Margin0.00%RSI (14)56.15Recom1.80
Dividend Gr. 3/5Y-Current Ratio24.00EPS Q/Q-61.76%SMA202.67%Beta1.00Target Price101.60
Payout0.00%Debt/Eq0.05Sales Q/Q-SMA503.28%Rel Volume3.47Prev Close70.21
Employees94LT Debt/Eq0.00EarningsAug 06SMA200-3.24%Avg Volume450.86KPrice70.79
IPO DateAug 12, 2020Option/ShortYes / YesEPS/Sales Surpr.-6.45% -Net Debt/EBITDA0.24Volume1,562,334Change0.83%
Analyst Ratings
DateActionAnalystRatingTarget
May-14-26ReiteratedMorgan StanleyOverweight$75 → $80
Feb-17-26ReiteratedMorgan StanleyOverweight$120 → $75
Feb-17-26ReiteratedStifel Nicolaus$125 → $110
Feb-17-26ReiteratedCantor FitzgeraldOverweight$125
Feb-17-26ReiteratedBMO CapitalOutperform$112 → $100
Feb-17-26ReiteratedWedbushOutperform$110 → $88
Jan-08-26ReiteratedMorgan StanleyOverweight$115 → $120
Dec-08-25ReiteratedRaymond JamesStrong Buy$108 → $117
Nov-10-25ReiteratedTruist Financial$86 → $114
Oct-17-25ReiteratedNational Bank$132 → $153
Latest News
Jun-17-26
Jun-17-2610:38AM
Disc Medicine: The CRL Has Created A Cleaner Bull CaseSeekingAlpha
Jun-16-26
Jun-16-2609:28AM
Morgan Stanley Maintains Overweight on Disc Medicine, Raises Price Target to $85Benzinga
Jun-15-26
Jun-15-2603:52PM
Disc Medicine, Inc. (IRON) Discusses Clinical Updates on Bitopertin, Selcodebart, and DISC-3405 and Strategic Outlook TranscriptSeekingAlpha
10:03AM
Disc Medicine, Inc. (IRON) Discusses Clinical Updates on Bitopertin, Selcodebart, and DISC-3405 and Strategic Outlook - SlideshowSeekingAlpha
Jun-10-26
Jun-10-2609:57AM
Wedbush Reiterates Outperform on Disc Medicine, Maintains $88 Price TargetBenzinga
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
Total Revenue
000
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A
000
Gross Profit
000
Selling, General and Administrative Excl. Other653322
Research and Development1719769
Other Operating Expense
000
Operating Income-236-130-91
Interest Expense410
Unusual Expense
———
Non-Operating Income (Expense)-28-21-15
Net Income Before Taxes-212-109-76
Income Taxes
000
Consolidated Net Income-212-109-76
Net Income From Continuing Operations-212-109-76
Net Income-212-109-76
EPS (Recurring)-6.01-3.96-3.42
EPS (Basic, Before Extraordinaries)-6.01-3.96-3.42
EPS (Diluted)-6.01-3.96-3.42
EBITDA-208-108-76
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio
———
Gross Margin
———
Operating Margin
———
Net Margin
———
Shares Outstanding352822
Market Capitalization2,779——
Operating Lease Expense
———
Insider Trading Volume
$77.14$71.39$65.64$59.89$54.13● Close Price0.00M18.56M37.12M55.67M74.23MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Franchi Jean M.Chief Financial OfficerApr 14 '26Sale69.246,257433,23464,333Apr 15 12:00 AM
Franchi Jean M.Chief Financial OfficerApr 13 '26Sale69.0040027,60070,590Apr 15 12:00 AM
Savage William JacobChief Medical OfficerApr 13 '26Sale66.385,731380,44979,480Apr 15 12:00 AM
Savage William JacobChief Medical OfficerMar 02 '26Sale65.887,378486,06985,211Mar 04 12:00 AM
Franchi Jean M.Chief Financial OfficerFeb 25 '26Sale69.0635324,37770,990Feb 27 12:00 AM
Franchi Jean M.Chief Financial OfficerFeb 18 '26Sale65.477,081463,57371,343Feb 19 12:00 AM
Franchi Jean M.Chief Financial OfficerFeb 17 '26Sale62.864,075256,15578,424Feb 19 12:00 AM
Quisel John DChief Executive OfficerFeb 17 '26Sale62.8613,264833,775226,064Feb 17 12:00 AM
Khara RahulChief Legal OfficerFeb 17 '26Sale62.862,853179,34052,173Feb 17 12:00 AM
Stephenson PamelaChief Commercial OfficerFeb 17 '26Sale62.865,531347,67980,998Feb 17 12:00 AM
Savage William JacobChief Medical OfficerFeb 17 '26Sale62.863,256204,67292,589Feb 17 12:00 AM
Yu Jonathan Yen-WenChief Operating OfficerFeb 17 '26Sale62.863,231203,10154,324Feb 17 12:00 AM
Khara RahulChief Legal OfficerJan 20 '26Option Exercise13.502,00027,00038,793Jan 21 12:00 AM
Khara RahulChief Legal OfficerJan 20 '26Sale69.741,00069,74037,793Jan 21 12:00 AM
Khara RahulChief Legal OfficerJan 02 '26Option Exercise13.5013,000175,50044,293Jan 05 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR